We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTN icon
2201
Gray Television
GTN
$498M
$285K ﹤0.01%
18,200
IIP
2202
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$284K ﹤0.01%
30,700
+11,500
+60% +$106K
ANDE icon
2203
Andersons Inc
ANDE
$2.23B
$283K ﹤0.01%
7,250
KN icon
2204
Knowles
KN
$3.33B
$283K ﹤0.01%
15,650
MTUS icon
2205
Metallus
MTUS
$900M
$283K ﹤0.01%
10,500
AAT
2206
American Assets Trust
AAT
$1.39B
$282K ﹤0.01%
7,200
ITRI icon
2207
Itron
ITRI
$4.49B
$282K ﹤0.01%
8,200
PHI icon
2208
PLDT
PHI
$4.24B
$281K ﹤0.01%
4,509
+475
+12% +$30.3K
EWA icon
2209
iShares MSCI Australia ETF
EWA
$1.46B
$280K ﹤0.01%
13,300
-12,700
-49% -$289K
MPAA icon
2210
Motorcar Parts of America
MPAA
$230M
$280K ﹤0.01%
9,300
GNCMA
2211
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$280K ﹤0.01%
16,470
OMN
2212
DELISTED
OMNOVA Solutions Inc.
OMN
$279K ﹤0.01%
37,300
THFF icon
2213
First Financial Corp
THFF
$970M
$277K ﹤0.01%
7,750
BBT
2214
Beacon Financial Corp
BBT
$2.69B
$276K ﹤0.01%
9,700
BTU
2215
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$276K ﹤0.01%
8,387
+3,340
+66% +$195K
IRC
2216
DELISTED
INLAND REAL ESTATE CORP
IRC
$276K ﹤0.01%
29,300
MTRN icon
2217
Materion
MTRN
$5.9B
$275K ﹤0.01%
7,800
VVUS
2218
DELISTED
Vivus Inc
VVUS
$275K ﹤0.01%
11,660
+5,860
+101% +$144K
RC
2219
Ready Capital
RC
$289M
$271K ﹤0.01%
16,769
+944
+6% +$16.4K
BZH icon
2220
Beazer Homes USA
BZH
$874M
$270K ﹤0.01%
13,520
ARGO
2221
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$270K ﹤0.01%
6,123
SGI
2222
DELISTED
Silicon Graphics Intl.
SGI
$270K ﹤0.01%
41,800
OVV icon
2223
Ovintiv
OVV
$17.5B
$269K ﹤0.01%
+4,880
New +$310K
QLGC
2224
DELISTED
QLOGIC CORP
QLGC
$269K ﹤0.01%
18,922
DCOM
2225
DELISTED
Dime Community Bancshares
DCOM
$269K ﹤0.01%
15,900

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.